ArticleOncotarget2016

Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers.

Maria Sofia Fernandes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.